Volume 8 (2022) – 48 articles

Cover Picture: Coming soon.

view this paper

Editorial

New developments in management of metastatic thyroid cancer

Jerome M. Hershman

This article belongs to the Special Issue Mechanism and Treatment of Thyroid Cancer

J Cancer Metastasis Treat 2022;8:3. DOI: 10.20517/2394-4722.2021.156

Editorial | Published on: 24 Jan 2022

Review

Promising therapeutic potential of tumor suppressor microRNAs for malignant pleural mesothelioma

Shivani Dixit, ... Chuong D. Hoang

This article belongs to the Special Issue Research Advances on Mesothelioma

J Cancer Metastasis Treat 2022;8:47. DOI: 10.20517/2394-4722.2022.70

Review | Published on: 4 Dec 2022

Immunotherapy in malignant pleural mesothelioma: a long story ended in success

Alberto Bongiovanni, ... Luana Calabrò

This article belongs to the Special Issue Research Advances on Mesothelioma

J Cancer Metastasis Treat 2022;8:44. DOI: 10.20517/2394-4722.2022.78

Review | Published on: 7 Oct 2022

Peritoneal mesothelioma

Yutaka Yonemura, ... Daisuke Fujimoto

This article belongs to the Special Issue Research Advances on Mesothelioma

J Cancer Metastasis Treat 2022;8:43. DOI: 10.20517/2394-4722.2022.49

Review | Published on: 27 Sep 2022

The heterogeneity of CAFs and immune cell populations in the tumor microenvironment of pancreatic adenocarcinoma

Maria Diab, Bassel F. El-Rayes

This article belongs to the Special Issue Role of Immune Cells in the Tumor Microenvironment

J Cancer Metastasis Treat 2022;8:42. DOI: 10.20517/2394-4722.2022.60

Review | Published on: 26 Sep 2022

Telemedicine for sarcoma patient care

Scott M. Schuetze

J Cancer Metastasis Treat 2022;8:41. DOI: 10.20517/2394-4722.2022.38

Review | Published on: 26 Sep 2022

The role of modern immunotherapy in metastatic urothelial cancer: mini review

Francesca Jackson-Spence, ... Thomas Powles

J Cancer Metastasis Treat 2022;8:40. DOI: 10.20517/2394-4722.2022.50

Review | Published on: 25 Sep 2022

The role of radiation therapy in the management of primary thymic epithelial neoplasms

Candice Johnstone, Charles B. Simone

This article belongs to the Special Issue The Pathology of Thymic Epithelial Tumors

J Cancer Metastasis Treat 2022;8:39. DOI: 10.20517/2394-4722.2021.211

Review | Published on: 18 Sep 2022

Neoadjuvant treatment of pancreatic ductal adenocarcinoma: present and future

Ioannis M. Koukourakis, ... Christos Papadimitriou

This article belongs to the Special Issue Treatment of Pancreatic Cancer

J Cancer Metastasis Treat 2022;8:38. DOI: 10.20517/2394-4722.2022.43

Review | Published on: 17 Sep 2022

Updates on the pathologic diagnosis and classification of mesothelioma

Julia R. Farkas, ... Jefree J. Schulte

This article belongs to the Special Issue Research Advances on Mesothelioma

J Cancer Metastasis Treat 2022;8:37. DOI: 10.20517/2394-4722.2022.89

Review | Published on: 8 Sep 2022

Reactive oxygen species in the progression and treatment of malignant mesothelioma

Ava Cote, ... Brian Cunniff

This article belongs to the Special Issue Research Advances on Mesothelioma

J Cancer Metastasis Treat 2022;8:36. DOI: 10.20517/2394-4722.2022.41

Review | Published on: 30 Aug 2022

Treatment strategies in cervical cancer: treatment of advanced disease

Augusto Valdivia, ... Ana Oaknin

This article belongs to the Special Issue Treatment Strategies of Cervical Cancer

J Cancer Metastasis Treat 2022;8:35. DOI: 10.20517/2394-4722.2022.34

Review | Published on: 24 Aug 2022

Determinants of prognosis in metastatic urothelial carcinoma: a review of the literature

Gavin Hui, ... Petros Grivas

J Cancer Metastasis Treat 2022;8:34. DOI: 10.20517/2394-4722.2022.04

Review | Published on: 21 Aug 2022

A shifting adversary: control of pancreatic cancer transcriptomic subtypes

Charles J. David

This article belongs to the Special Issue Treatment of Pancreatic Cancer

J Cancer Metastasis Treat 2022;8:32. DOI: 10.20517/2394-4722.2022.71

Review | Published on: 21 Aug 2022

Germline predisposition to soft tissue sarcoma

Jennie Vagher, ... Luke Maese

J Cancer Metastasis Treat 2022;8:31. DOI: 10.20517/2394-4722.2022.31

Review | Published on: 18 Aug 2022

The role of systemic therapy in borderline resectable and locally advanced pancreatic ductal adenocarcinoma

Victor C. K. Lo, ... Michael M. Vickers

This article belongs to the Special Issue Treatment of Pancreatic Cancer

J Cancer Metastasis Treat 2022;8:30. DOI: 10.20517/2394-4722.2022.48

Review | Published on: 14 Aug 2022

Utility of circulating tumor DNA for predicting prognosis in the management of resectable pancreatic cancer

Zachary Tyerman, ... Akhil Chawla

This article belongs to the Special Issue Treatment of Pancreatic Cancer

J Cancer Metastasis Treat 2022;8:29. DOI: 10.20517/2394-4722.2022.20

Review | Published on: 28 Jul 2022

Overcoming tumor antigen heterogeneity in CAR-T cell therapy for malignant mesothelioma (MM)

Reena R. D'Souza, ... Astero Klampatsa

This article belongs to the Special Issue Research Advances on Mesothelioma

J Cancer Metastasis Treat 2022;8:28. DOI: 10.20517/2394-4722.2022.51

Review | Published on: 27 Jul 2022

Role of myeloid cells in the tumor microenvironment

Arpita Balakrishnan, ... Shweta Dubey

This article belongs to the Special Issue Role of Immune Cells in the Tumor Microenvironment

J Cancer Metastasis Treat 2022;8:27. DOI: 10.20517/2394-4722.2022.33

Review | Published on: 25 Jul 2022

Current and future opportunities for liquid biopsy of circulating biomarkers to aid in early cancer detection

Susan H. Gawel, ... Gerard J. Davis

This article belongs to the Special Issue Liquid Biopsies in Cancer Early Diagnosis

J Cancer Metastasis Treat 2022;8:26. DOI: 10.20517/2394-4722.2022.13

Review | Published on: 28 Jun 2022

The peripheral T-cell lymphoma: can we pivot from the chemotherapy-predicated paradigm?

Helen Ma, Enrica Marchi

This article belongs to the Special Issue Advancing the Care of Non-Hodgkins Lymphoma (NHL): Steps Towards Being Chemo-Free

J Cancer Metastasis Treat 2022;8:25. DOI: 10.20517/2394-4722.2022.17

Review | Published on: 28 Jun 2022

The role of VISTA in the tumor microenvironment

Dina Rabadi, ... J. Louise Lines

This article belongs to the Special Issue Role of Immune Cells in the Tumor Microenvironment

J Cancer Metastasis Treat 2022;8:24. DOI: 10.20517/2394-4722.2022.06

Review | Published on: 21 Jun 2022

Lymph node metastasis from non-melanoma skin cancer

Robbie S. R. Woods, ... Jatin P. Shah

This article belongs to the Special Issue Lymph Node Metastases in the Neck

J Cancer Metastasis Treat 2022;8:22. DOI: 10.20517/2394-4722.2022.28

Review | Published on: 26 May 2022

Follicular lymphoma: the diminishing role of chemotherapy

Beatrice Casadei, ... Pier Luigi Zinzani

This article belongs to the Special Issue Advancing the Care of Non-Hodgkins Lymphoma (NHL): Steps Towards Being Chemo-Free

J Cancer Metastasis Treat 2022;8:21. DOI: 10.20517/2394-4722.2022.05

Review | Published on: 25 May 2022

Tumors due to chronic exposure to benzene and biomarkers of exposure

Gilda Alves, ... Maria Helena Faria Ornellas

J Cancer Metastasis Treat 2022;8:20. DOI: 10.20517/2394-4722.2022.02

Review | Published on: 19 May 2022

Molecular pathology of thymoma and thymic carcinoma

David I. Suster, ... A. Craig Mackinnon

This article belongs to the Special Issue The Pathology of Thymic Epithelial Tumors

J Cancer Metastasis Treat 2022;8:19. DOI: 10.20517/2394-4722.2021.210

Review | Published on: 16 May 2022

Anti-angiogenic drugs in cancer therapeutics: a review of the latest preclinical and clinical studies of anti-angiogenic agents with anticancer potential

Polyxeni Vafopoulou, Malamati Kourti

This article belongs to the Special Issue Research Advances on Tumor-Induced Angiogenesis

J Cancer Metastasis Treat 2022;8:18. DOI: 10.20517/2394-4722.2022.08

Review | Published on: 5 May 2022

Combining oncolytic virus and radiation therapy for cancer management

Vito Filbert Jayalie, Sri Mutya Sekarutami

J Cancer Metastasis Treat 2022;8:17. DOI: 10.20517/2394-4722.2021.212

Review | Published on: 28 Apr 2022

Thymic carcinoma: review and update

Kirill Karlin, Phillip D. Michaels

This article belongs to the Special Issue The Pathology of Thymic Epithelial Tumors

J Cancer Metastasis Treat 2022;8:15. DOI: 10.20517/2394-4722.2021.185

Review | Published on: 7 Apr 2022

Chronic activation of MUC1-C in wound repair promotes progression to cancer stem cells

Donald W. Kufe

J Cancer Metastasis Treat 2022;8:12. DOI: 10.20517/2394-4722.2022.03

Review | Published on: 30 Mar 2022

Diffuse large B-Cell lymphoma: from novel molecular classifications to tailored targeted therapies

Jennifer K. Lue, Grzegorz S. Nowakowski

This article belongs to the Special Issue Advancing the Care of Non-Hodgkins Lymphoma (NHL): Steps Towards Being Chemo-Free

J Cancer Metastasis Treat 2022;8:11. DOI: 10.20517/2394-4722.2021.193

Review | Published on: 30 Mar 2022

The bone marrow niche landscape: a journey through aging, extrinsic and intrinsic stressors in the haemopoietic milieu

Antonio Giovanni Solimando, ... Roberto Ria

This article belongs to the Special Issue Angiogenesis and Antiangiogenesis in Hematological Malignancies

J Cancer Metastasis Treat 2022;8:9. DOI: 10.20517/2394-4722.2021.166

Review | Published on: 17 Mar 2022

The WHO 2021 thymoma classification: a work in progress

Saul Suster

This article belongs to the Special Issue The Pathology of Thymic Epithelial Tumors

J Cancer Metastasis Treat 2022;8:7. DOI: 10.20517/2394-4722.2021.203

Review | Published on: 11 Mar 2022

The role of radiotherapy in metastatic bladder cancer

Jananie Perera, Peter Hoskin

J Cancer Metastasis Treat 2022;8:4. DOI: 10.20517/2394-4722.2021.167

Review | Published on: 24 Jan 2022

The role of MT1-MMP in the progression and metastasis of osteosarcoma

Hannah L. M. Spencer, ... Robert A. Falconer

This article belongs to the Special Issue Bone Microenvironment and Bone Metastasis

J Cancer Metastasis Treat 2022;8:2. DOI: 10.20517/2394-4722.2021.174

Review | Published on: 13 Jan 2022

Biomarkers for therapy selection in metastatic urothelial cancer

Tomi Jun, ... Matthew D. Galsky

J Cancer Metastasis Treat 2022;8:1. DOI: 10.20517/2394-4722.2021.171

Review | Published on: 11 Jan 2022

Original Article

Diagnostic accuracy of MRI and PET/CT for neck staging prior to salvage total laryngectomy

Jonas Galli, ... Lluís Nisa

This article belongs to the Special Issue Lymph Node Metastases in the Neck

J Cancer Metastasis Treat 2022;8:48. DOI: 10.20517/2394-4722.2022.19

Original Article | Published on: 22 Dec 2022

The safety and efficacy of palbociclib in older patients with advanced breast cancer in a real-world setting

Etienne Gouton, ... Frederique Rousseau

This article belongs to the Special Issue Breast Cancer Metastasis

J Cancer Metastasis Treat 2022;8:33. DOI: 10.20517/2394-4722.2022.64

Original Article | Published on: 21 Aug 2022

Sensitivity of MCF-7 mammosphere CSCs to neutron radiation

Valentina G. Shuvatova, ... Elizaveta Yu Moskaleva

J Cancer Metastasis Treat 2022;8:23. DOI: 10.20517/2394-4722.2022.29

Original Article | Published on: 29 May 2022

Surgical route and pathological risk factors in early cervical cancer - Node Zero (SURPEC-N0)

T S Shylasree, ... Rajendra Kerkar

This article belongs to the Special Issue Treatment Strategies of Cervical Cancer

J Cancer Metastasis Treat 2022;8:14. DOI: 10.20517/2394-4722.2022.10

Original Article | Published on: 6 Apr 2022

Final results of a 2:1 control-case observational study using interferon beta and interleukin-2, in addition to first-line hormone therapy, in estrogen receptor-positive, endocrine-responsive metastatic breast cancer patients

Andrea Nicolini, ... Angelo Carpi

J Cancer Metastasis Treat 2022;8:13. DOI: 10.20517/2394-4722.2021.209

Original Article | Published on: 6 Apr 2022

Combined effects of oncolytic vaccinia virus and dendritic cells on the progression of melanoma B16-F10 in mice

Elena P. Goncharova, ... Marina A. Zenkova

J Cancer Metastasis Treat 2022;8:10. DOI: 10.20517/2394-4722.2021.195

Original Article | Published on: 17 Mar 2022

Serum squamous cell carcinoma antigen is a predictive factor of outcomes in patients with locally advanced unresectable esophageal squamous cell carcinoma treated by definitive chemoradiotherapy

Takeshi Suzuki, ... Keisho Chin

This article belongs to the Special Issue Management of Esophageal Cancer

J Cancer Metastasis Treat 2022;8:5. DOI: 10.20517/2394-4722.2021.160

Original Article | Published on: 24 Jan 2022

Opinion

More efficient clinical trials in pancreatic cancer: develop better treatment options, faster

Allison Rosenzweig, ... Lynn M. Matrisian

This article belongs to the Special Issue Treatment of Pancreatic Cancer

J Cancer Metastasis Treat 2022;8:46. DOI: 10.20517/2394-4722.2022.58

Opinion | Published on: 18 Oct 2022

Radiomics in sarcoma trials: a complement to RECIST for patient assessment

Caryn Geady, ... Benjamin Haibe-Kains

J Cancer Metastasis Treat 2022;8:45. DOI: 10.20517/2394-4722.2022.57

Opinion | Published on: 7 Oct 2022

Tricking the tumour microenvironment into becoming our best rational drug design factory: reversal of immune suppression

Martin L. Ashdown

This article belongs to the Special Issue Role of Immune Cells in the Tumor Microenvironment

J Cancer Metastasis Treat 2022;8:6. DOI: 10.20517/2394-4722.2022.01

Opinion | Published on: 27 Feb 2022

Case Report

Angiogenesis and osteopontin expression in paraskeletal myeloma with plasmablastic morphology and aggressive clinical course: a report of two cases

Toni Valković, ... Nives Jonjić

This article belongs to the Special Issue Angiogenesis and Antiangiogenesis in Hematological Malignancies

J Cancer Metastasis Treat 2022;8:16. DOI: 10.20517/2394-4722.2021.208

Case Report | Published on: 23 Apr 2022

Perspective

Moving towards the chemo-free treatment of lymphoma: hype or reality?

Bruce D. Cheson

This article belongs to the Special Issue Advancing the Care of Non-Hodgkins Lymphoma (NHL): Steps Towards Being Chemo-Free

J Cancer Metastasis Treat 2022;8:8. DOI: 10.20517/2394-4722.2021.153

Perspective | Published on: 17 Mar 2022

Actions for 0 selected articles